CIK 0001725430 · Non-accelerated filer<br>Smaller reporting company
INTELLIGENT BIO SOLUTIONS INC.
Sign in to watch- Ticker
- INBS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821512711
- Phone
- 646-790-5756
- Business address
- 135 W 41ST ST,, FLOOR 5, NEW YORK, NY, 10036
- Former names
- GBS Inc., Glucose Biosensor Systems (Greater China) Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-31 | Simeonidis Harry CEO | Purchase | +100 | $1.92 | $192 | 4,130 |
| 2023-05-10 | Sakiris Spiro Kevin Chief Financial Officer | Conversion | +2,399 | $5.80 | $14K | 4,745 |
| 2023-05-10 | Sakiris Spiro Kevin Chief Financial Officer | Conversion · Series D Convertible Preferred Stock | −15,993 | 0 | ||
| 2022-12-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Series D Convertible Preferred Stock | +15,992 | $0.87 | $14K | 15,993 |
| 2022-12-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase · Common Stock Purchase Warrant | +47,979 | $0.13 | $6K | 47,979 |
| 2022-10-10 | Simeonidis Harry President | Grant or award | +80,000 | 80,600 | ||
| 2022-10-10 | Hurd Jonathan Scott Director | Grant or award | +15,000 | 15,000 | ||
| 2022-10-10 | TOWERS CHRISTOPHER Director | Grant or award | +15,000 | 15,800 | ||
| 2022-10-10 | Margelis George Director | Grant or award | +15,000 | 15,000 | ||
| 2022-10-10 | FISHER LAWRENCE B Director | Grant or award | +15,000 | 15,000 | ||
| 2022-10-10 | Boyages Steven Constantine Interim CEO and Chairperson | Grant or award | +75,000 | 75,000 | ||
| 2022-10-10 | Sakiris Spiro Kevin Chief Financial Officer | Grant or award | +75,000 | 125,228 | ||
| 2022-06-22 | Sakiris Spiro Kevin Chief Financial Officer | Purchase | +5,000 | $0.65 | $3K | 50,228 |
| 2022-06-17 | Sakiris Spiro Kevin ChiefFinancial Officer | Purchase | +15,970 | $0.61 | $10K | 45,228 |
| 2022-02-17 | Life Science Biosensor Diagnostics Pty Ltd Former 10% owner | Sale | −576,028 | $0.51 | $294K | 1,081,804 |
| 2022-02-16 | Life Science Biosensor Diagnostics Pty Ltd 10% owner | Sale | −100,000 | $0.63 | $63K | 1,657,832 |
| 2022-02-15 | Life Science Biosensor Diagnostics Pty Ltd 10% owner | Sale | −100,000 | $0.68 | $68K | 1,757,832 |
| 2022-02-14 | Life Science Biosensor Diagnostics Pty Ltd 10% owner | Sale | −100,000 | $0.70 | $70K | 1,857,832 |
| 2022-02-11 | Life Science Biosensor Diagnostics Pty Ltd 10% owner | Sale | −100,000 | $0.75 | $75K | 1,957,832 |
| 2022-02-10 | Life Science Biosensor Diagnostics Pty Ltd 10% owner | Sale | −100,000 | $0.84 | $84K | 2,057,832 |
Page 2 of 4 · 77 trades